CASI Pharmaceuticals, Inc. (CASIF)
0.12
+0.01
(+14.18%)
USD |
OTCM |
May 21, 16:00
CASI Pharmaceuticals EPS Diluted (Quarterly) : -0.6345 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| Zai Lab Ltd. | -0.4621 |
| Ascletis Pharma, Inc. | -- |
| CanSino Biologics, Inc. | -0.0236 |
| CStone Pharmaceuticals Co. Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.04M |
| Revenue (Quarterly) | 7.222M |
| Total Expenses (Quarterly) | 20.26M |
| Enterprise Value | 24.32M |
| Gross Profit Margin (Quarterly) | 51.14% |
| Profit Margin (Quarterly) | -180.6% |
| Earnings Yield | -2.39K% |
| Normalized Earnings Yield | -2384.17 |